GO:0042562 hormone binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042562 hormone binding is a molecular function defined as binding to a hormone, a naturally occurring substance secreted by specialized cells that affects the metabolism or behavior of cells possessing functional receptors for the hormone.
• Hormone binding underpins endocrine signaling and is mediated by receptor proteins such as nuclear receptors, G-protein-coupled receptors, and cytokine receptor family members.
• The androgen receptor exemplifies how selective DNA binding by a hormone-bound receptor leads to hormone-specific gene regulation.
• Hormone binding is central to growth, metabolism, reproduction, and stress responses, with growth hormone, testosterone, IGFs, and cortisol integrating cellular development.
• Exercise training and aging alter anabolic and catabolic hormone levels, demonstrating the physiological plasticity of hormone-binding systems.
• Dysregulated hormone binding is implicated in metabolic, reproductive, and neurological disorders, including polycystic ovary syndrome and epilepsy.
Description
Hormone binding (GO:0042562) is a molecular function that describes the interaction between a hormone and its target molecule, typically a receptor protein. Hormones are naturally occurring substances secreted by specialized cells that affect the metabolism or behavior of cells possessing functional receptors for the hormone. This binding event is the first step in endocrine signaling and is essential for coordinating growth, metabolism, reproduction, and stress responses across tissues. The specificity of hormone binding determines which cells respond to a given hormonal signal, making it a fundamental mechanism in physiology and disease. At the molecular level, hormone binding involves non-covalent interactions between the hormone ligand and a binding pocket in the receptor. For steroid hormones such as androgens, binding to the androgen receptor induces conformational changes that allow the receptor to selectively bind DNA and regulate gene expression. For peptide hormones such as growth hormone, binding to cell-surface receptors triggers intracellular signaling cascades that modulate cellular development and growth. The diversity of hormone-binding proteins reflects the wide range of hormonal signals and their physiological roles. Researchers study hormone binding to understand endocrine regulation, identify therapeutic targets, and dissect disease mechanisms. For example, gonadotropin-releasing hormone antagonists block hormone binding to treat hormone-dependent conditions, while gut-derived hormones regulate cholesterol metabolism through receptor-mediated binding. This article reviews the definition, mechanisms, key genes, research models, and methods relevant to GO:0042562, providing a resource for investigators studying hormone-receptor interactions.
hormone binding At A Glance
| GO ID | GO:0042562 |
|---|---|
| GO term | hormone binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to a hormone, enabling endocrine signaling and receptor activation |
| Definition source | QuickGO |
| Examples of hormones | Growth hormone, testosterone, insulin-like growth factors, cortisol, gut-derived hormones |
| Associated receptors | Androgen receptor, growth hormone receptor, G-protein-coupled receptors |
| Physiological contexts | Growth, metabolism, reproduction, stress, exercise adaptation |
What Is GO:0042562?
GO:0042562 hormone binding is defined as the binding to a hormone, a naturally occurring substance secreted by specialized cells that affect the metabolism or behavior of cells possessing functional receptors for the hormone. Hormones may be produced by the same, or different, cell as express the receptor. This molecular function encompasses the physical interaction between a hormone ligand and its binding partner, which is typically a receptor protein, and is a prerequisite for downstream signal transduction and cellular responses.
Why Is hormone binding Important in Cell Biology?
Hormone binding is a cornerstone of endocrine physiology and is essential for intercellular communication. It enables hormones secreted by specialized cells to act on target cells expressing functional receptors, thereby coordinating metabolism, growth, reproduction, and behavior. Disruption of hormone binding can lead to endocrine disorders, metabolic diseases, and cancers, making it a critical area of biomedical research. Understanding hormone binding also informs the development of therapeutics such as receptor antagonists and hormone replacement therapies.
• Hormone binding initiates endocrine signaling that regulates metabolism, growth, and reproduction.
• It provides specificity to hormonal responses by determining which cells respond to a given hormone.
• Growth hormone, testosterone, IGFs, and cortisol integrate cellular development and growth with exercise.
• Exercise training and aging modulate anabolic and catabolic hormones, affecting muscle and bone health.
• Gut-derived hormones regulate cholesterol metabolism through receptor binding.
• Gonadotropin-releasing hormone antagonists are used clinically to block hormone binding in hormone-dependent conditions.
• Hormone binding is relevant to mycologic endocrinology, where fungal hormones influence growth and virulence.
• Intermittent fasting alters hormones in women with polycystic ovary syndrome, highlighting lifestyle effects on hormone binding.
• Epilepsy and hormones are interconnected, with hormonal changes influencing seizure susceptibility.
• Selective DNA binding by the androgen receptor after hormone binding drives hormone-specific gene regulation.
Molecular Mechanism of hormone binding
Hormone recognition and binding pocket
In simple terms: The receptor has a specially shaped pocket that fits a specific hormone like a lock and key.
Hormone binding begins with the recognition of a specific hormone by a binding pocket in its receptor. For steroid hormones such as androgens, the ligand-binding domain of the androgen receptor forms a hydrophobic pocket that accommodates the hormone with high specificity. For peptide hormones like growth hormone, the receptor ectodomain provides complementary surfaces for hormone docking. The binding affinity and specificity are determined by non-covalent interactions, including hydrogen bonds, hydrophobic contacts, and electrostatic interactions.
Conformational change and receptor activation
In simple terms: When the hormone binds, the receptor changes shape and becomes active.
Hormone binding induces conformational changes in the receptor that are essential for signal transduction. In the androgen receptor, ligand binding triggers a conformational shift that releases heat shock proteins and exposes DNA-binding and transactivation domains. For growth hormone receptor, ligand-induced dimerization activates associated Janus kinases and downstream signaling pathways. These structural changes convert the binding event into a functional cellular response.
Signal transduction and gene regulation
In simple terms: The activated receptor sends signals that turn genes on or off.
Following activation, hormone-bound receptors propagate signals through intracellular cascades. Nuclear receptors such as the androgen receptor translocate to the nucleus, bind specific DNA response elements, and regulate target gene transcription. Cell-surface receptors for peptide hormones activate second messenger systems, including cyclic AMP and kinase cascades, that modulate gene expression and cellular metabolism. Gut-derived hormones can regulate cholesterol metabolism through receptor-mediated signaling pathways.
Integration with metabolic and growth pathways
In simple terms: Hormone binding connects to broader networks that control growth and metabolism.
Hormone binding is integrated with anabolic and catabolic pathways that control cellular development and growth. Growth hormone, testosterone, insulin-like growth factors, and cortisol act in concert to regulate protein synthesis, muscle hypertrophy, and energy balance. Exercise training alters the secretion and binding of these hormones, demonstrating the dynamic regulation of hormone-binding systems with age and physical activity. These integrative roles highlight the importance of hormone binding in whole-body physiology.
Regulation by antagonists and feedback
In simple terms: Other molecules can block hormone binding, and feedback loops adjust hormone levels.
Hormone binding can be modulated by antagonists that compete for the receptor binding site. Gonadotropin-releasing hormone antagonists block hormone binding to their receptors, thereby suppressing downstream signaling and hormone release. Endogenous feedback mechanisms also regulate hormone availability and receptor sensitivity, ensuring homeostatic control of endocrine axes. These regulatory layers provide opportunities for therapeutic intervention in hormone-dependent diseases.
Key Genes Involved in GO:0042562 hormone binding
The following genes encode receptors and binding proteins that mediate hormone binding (GO:0042562) and are frequently studied in endocrine research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AR | Androgen receptor; binds testosterone and dihydrotestosterone | Selective DNA binding and hormone-specific gene regulation |
| GHR | Growth hormone receptor; binds growth hormone | Mediates growth and metabolic effects of growth hormone |
| IGF1R | Insulin-like growth factor 1 receptor; binds IGF-1 | Regulates cellular development and growth with exercise |
| NR3C1 | Glucocorticoid receptor; binds cortisol | Stress response and catabolic hormone signaling |
| GNRHR | Gonadotropin-releasing hormone receptor | Target of GnRH antagonists for hormone-dependent conditions |
| INSR | Insulin receptor; binds insulin | Metabolic regulation and integration with growth pathways |
| LEPR | Leptin receptor; binds leptin | Energy balance and neuroendocrine regulation |
| FSHR | Follicle-stimulating hormone receptor | Reproductive hormone binding and ovarian function |
| LHCGR | Luteinizing hormone/choriogonadotropin receptor | Reproductive hormone signaling |
| ESR1 | Estrogen receptor alpha; binds estrogens | Hormone-dependent gene regulation and cancer biology |
| ESR2 | Estrogen receptor beta; binds estrogens | Tissue-specific estrogen signaling |
| PGR | Progesterone receptor; binds progesterone | Reproductive and mammary biology |
| THRA | Thyroid hormone receptor alpha; binds thyroid hormone | Metabolic and developmental regulation |
| THRB | Thyroid hormone receptor beta; binds thyroid hormone | Metabolic and sensory functions |
| VDR | Vitamin D receptor; binds calcitriol | Calcium homeostasis and immune modulation |
| PPARG | Peroxisome proliferator-activated receptor gamma; binds fatty acids | Metabolic and inflammatory regulation |
| GCG | Glucagon; binds glucagon receptor | Glucose metabolism and gut-derived hormone signaling |
How Is hormone binding Regulated?
Hormone binding is regulated at multiple levels, including hormone availability, receptor expression, and post-translational modifications. Feedback loops in the hypothalamic-pituitary-adrenal and gonadal axes adjust hormone secretion and receptor sensitivity to maintain homeostasis. Exercise training and aging alter the concentrations of anabolic and catabolic hormones, thereby modulating hormone binding and downstream signaling. Antagonists such as gonadotropin-releasing hormone antagonists can competitively inhibit hormone binding, providing pharmacological control. Additionally, gut-derived hormones regulate cholesterol metabolism through receptor-mediated mechanisms, illustrating the integration of hormone binding with metabolic regulation.
hormone binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AR | Prostate cancer; androgen insensitivity | AR knockout or point-mutation cell lines |
| GHR | Growth hormone deficiency; Laron syndrome | GHR knockout models |
| GNRHR | Hypogonadotropic hypogonadism; hormone-dependent conditions | GnRH antagonist treatment models |
| ESR1 | Breast cancer; estrogen-dependent disorders | ESR1 knockout or knock-in models |
| LEPR | Obesity; metabolic syndrome | LEPR knockout models |
Hormone binding in metabolic disorders
Dysregulated hormone binding contributes to metabolic disorders such as polycystic ovary syndrome (PCOS), where intermittent fasting alters anthropometric measurements, metabolic profiles, and hormone levels. Gut-derived hormones that regulate cholesterol metabolism represent another link between hormone binding and metabolic control. These findings suggest that targeting hormone-binding pathways may offer therapeutic strategies for metabolic diseases.
Hormone binding in reproductive and endocrine cancers
The androgen receptor binds testosterone and dihydrotestosterone, and its selective DNA binding after hormone binding drives hormone-specific gene regulation that is critical in prostate cancer biology. Estrogen receptor binding of estrogens similarly influences breast cancer development and progression. Gonadotropin-releasing hormone antagonists that block hormone binding are used to treat hormone-dependent cancers and other conditions.
Hormone binding in neurological and infectious contexts
Epilepsy and hormones are interconnected, with hormonal fluctuations influencing seizure susceptibility and neurological function. In mycologic endocrinology, fungal hormones and their binding proteins affect growth and virulence, highlighting the broad relevance of hormone binding beyond human physiology. These examples underscore the diverse disease contexts in which hormone binding plays a role.
From hormone binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of AR abolish androgen binding and gene regulation? | AR knockout cell line |
| Does a point mutation in the ligand-binding domain alter hormone specificity? | AR point-mutation knock-in |
| Can a tagged receptor track hormone binding dynamics? | Tagged knock-in of AR or GHR |
| Does overexpression of GHR enhance growth hormone sensitivity? | GHR overexpression cell model |
| Does GnRH antagonist block hormone binding in vivo? | GnRH antagonist-treated animal model |
| Does intermittent fasting alter hormone binding in PCOS? | PCOS patient-derived cell models |
How to Study the hormone binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding assay | Binding affinity and receptor density | Characterizing androgen receptor binding |
| Luciferase reporter assay | Hormone-dependent transcriptional activity | Testing receptor activation |
| CRISPR knockout screen | Genes required for hormone binding | Discovering novel regulators |
| Co-immunoprecipitation | Protein-protein interactions in hormone-bound complexes | Identifying receptor partners |
| Mass spectrometry | Hormone-receptor complex composition | Mapping binding interfaces |
| Immunofluorescence | Subcellular localization of receptors | Tracking nuclear translocation |
| ELISA | Hormone concentrations in biological samples | Measuring exercise-induced hormone changes |
| qPCR | Expression of hormone-responsive genes | Assessing downstream signaling |
Ligand binding assays
Radioligand or fluorescent ligand binding assays measure the affinity and specificity of hormone-receptor interactions. These methods are used to characterize androgen receptor binding to testosterone and to screen for antagonists such as GnRH antagonists.
Transcriptional reporter assays
Reporter gene assays assess hormone-dependent transcriptional activation following receptor binding. They are widely used to study selective DNA binding by the androgen receptor and hormone-specific gene regulation.
CRISPR-based genetic screens
CRISPR knockout and activation screens can identify genes required for hormone binding and downstream signaling. These screens are valuable for discovering novel regulators of endocrine pathways.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify hormone-receptor complexes and post-translational modifications that regulate binding. This approach helps map the molecular machinery of hormone binding.
How CRISPR Can Be Used to Study GO:0042562 hormone binding
Knockout
CRISPR knockout of hormone receptor genes such as AR or GHR abolishes hormone binding and downstream signaling, enabling researchers to study loss-of-function phenotypes in endocrine cells.
Point Mutation
Point mutations in ligand-binding domains can alter hormone specificity or affinity. CRISPR-mediated point mutation knock-in models are used to dissect the structural determinants of hormone binding.
Knock-in
Knock-in of tagged receptors or reporter cassettes allows real-time tracking of hormone binding and receptor trafficking in live cells.
Overexpression
Overexpression of hormone receptors or binding proteins can sensitize cells to hormonal signals and is used to study gain-of-function effects in metabolic and reproductive research.
How EDITGENE Supports hormone binding Research
Researchers studying hormone binding-related genes often need to determine whether a candidate gene is causally involved in endocrine signaling, receptor activation, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for hormone binding research.
Frequently Asked Questions About hormone binding
What is GO:0042562 hormone binding?
GO:0042562 hormone binding is a molecular function defined as binding to a hormone, a naturally occurring substance secreted by specialized cells that affects the metabolism or behavior of cells possessing functional receptors for the hormone.
What genes are involved in hormone binding?
Key genes include AR, GHR, IGF1R, NR3C1, GNRHR, INSR, LEPR, FSHR, LHCGR, ESR1, ESR2, PGR, THRA, THRB, VDR, and PPARG, which encode hormone receptors and binding proteins.
How does hormone binding regulate gene expression?
Hormone binding induces conformational changes in receptors such as the androgen receptor, enabling selective DNA binding and hormone-specific gene regulation.
What diseases are associated with hormone binding?
Hormone binding is implicated in metabolic disorders like PCOS, reproductive cancers such as prostate and breast cancer, and neurological conditions like epilepsy.
How can I study hormone binding using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect hormone-receptor interactions and downstream signaling.
What methods measure hormone binding affinity?
Radioligand binding assays, reporter assays, and proteomics are commonly used to measure hormone binding affinity and receptor activation.
What is the role of androgen receptor in hormone binding?
The androgen receptor binds testosterone and dihydrotestosterone, and its selective DNA binding after hormone binding drives hormone-specific gene regulation.
How does exercise affect hormone binding?
Exercise training alters anabolic and catabolic hormone levels, including growth hormone, testosterone, IGFs, and cortisol, thereby modulating hormone binding and cellular development.
What are gonadotropin-releasing hormone antagonists?
GnRH antagonists block hormone binding to GnRH receptors, suppressing downstream signaling and hormone release, and are used clinically for hormone-dependent conditions.
Can hormone binding be studied in fungal systems?
Yes, mycologic endocrinology studies fungal hormones and their binding proteins, which influence growth and virulence.
Conclusion
Hormone binding (GO:0042562) is a fundamental molecular function that mediates endocrine signaling and regulates diverse physiological processes, including growth, metabolism, reproduction, and stress responses. The specificity of hormone-receptor interactions determines cellular responses and is critical for normal physiology and disease prevention. Dysregulated hormone binding contributes to metabolic, reproductive, and neurological disorders, making it an important therapeutic target. Advances in CRISPR-based models and bioinformatics are accelerating research into hormone binding mechanisms and their clinical applications.
References
- 1. Hu X et al.. 2024. A gut-derived hormone regulates cholesterol metabolism.. Cell 187(7):1685-1700.e18 PMID: 38503280
- 2. Kraemer WJ et al.. 2020. Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise.. Front Endocrinol (Lausanne) 11:33 PMID: 32158429
- 3. Zouhal H et al.. 2022. Effects of Exercise Training on Anabolic and Catabolic Hormones with Advanced Age: A Systematic Review.. Sports Med 52(6):1353-1368 PMID: 34936049
- 4. Herbst KL. 2003. Gonadotropin-releasing hormone antagonists.. Curr Opin Pharmacol 3(6):660-6 PMID: 14644020
- 5. Clemons KV et al.. 2016. Mycologic Endocrinology.. Adv Exp Med Biol 874:337-63 PMID: 26589227
- 6. Claessens F et al.. 2001. Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation.. J Steroid Biochem Mol Biol 76(1-5):23-30 PMID: 11384860
- 7. Ranneh Y et al.. 2025. Effect of Intermittent Fasting on Anthropometric Measurements, Metabolic Profile, and Hormones in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.. Nutrients 17(15) PMID: 40806019
- 8. Motta E. 2000. [Epilepsy and hormones].. Neurol Neurochir Pol 34 Suppl 1:31-6 PMID: 10768143
